US 9938344
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 9938344 (Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer) held by PRECISION BIOLOGICS, INC. expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P